In Romanian In Albanian In Bulgarian In Serbian In Macedonian
North Macedonia's leading pharmaceutical company Alkaloid has announced the creation of a new wholly-owned subsidiary in Croatia, BalkanEngineer.co has learned from SeeNews.com. Named Alkaloid Pharma International Doo Zagreb, the newly registered company marks a significant step in Alkaloid's broader strategy to deepen its footprint in Europe.
Exports currently account for a significant 69% of Alkaloid's product distribution, and a presence in Croatia will not only diversify the company's operations, but is also in line with its ambition to expand its reach within the EU market.
Alkaloid Pharma International Doo Zagreb represents Alkaloid's eighth European-based entity. This expansion reflects the company's proactive approach to adapting to global market dynamics and its commitment to secure a significant market presence in the region.
On the financial front, Alkaloid's shares have demonstrated a solid performance, trading at an average price of MKD 20,100 (approximately EUR 326.7) per share on the Macedonian Stock Exchange according to recent data. This financial position is indicative of Alkaloid's strong market position and investor confidence in its strategic direction and operational efficiency.
Photo source: canva.com